LIPPS RANDALL A
Known title: Chairman, President and CEOCIK: 0001227556
LIPPS RANDALL A's purchase track record
LIPPS RANDALL A has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/14/2025 | OMCL | $350K | -11.4% | -3.5% | +16.8% |
| 6/8/2023 | OMCL | $295K | -24.5% | -52.2% | +6.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OMCL | ▼ Sell | Tax Withholding | 12,350 | $461K | 8/15/2026 | View on chart |
| OMCL | ▼ Sell | Open Market | 10,000 | $470K | 7/15/2026 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 12,347 | $532K | 5/15/2026 | View on chart |
| OMCL | ▲ Buy | Grant | 90,939 | $0 | 4/1/2026 | View on chart |
| OMCL | ▲ Buy | Grant | 79,494 | $0 | 3/15/2026 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 15,642 | $538K | 3/15/2026 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 5,294 | $193K | 2/15/2026 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 1,147 | $50K | 12/15/2025 | View on chart |
| OMCL | ▲ Buy | Option Exercise | 28,250 | $783K | 12/1/2025 | View on chart |
| OMCL | ▼ Sell | Open Market | 28,250 | $1.0M | 12/1/2025 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 8,437 | $296K | 11/15/2025 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 8,438 | $267K | 8/15/2025 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 1,146 | $34K | 6/15/2025 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 8,435 | $237K | 5/15/2025 | View on chart |
| OMCL | ▲ Buy | Grant | 79,494 | $0 | 3/15/2025 | View on chart |
| OMCL | ▲ Buy | Open Market | 10,561 | $350K | 3/14/2025 | View on chart |
| OMCL | ▲ Buy | Grant | 188,794 | $0 | 3/8/2025 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 18,571 | $687K | 3/8/2025 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 6,652 | $253K | 3/1/2025 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 756 | $30K | 2/15/2025 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 4,202 | $193K | 12/15/2024 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 1,155 | $53K | 11/15/2024 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 6,043 | $259K | 8/15/2024 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 2,599 | $73K | 6/15/2024 | View on chart |
| OMCL | ▲ Buy | Grant | 107,251 | $0 | 2/27/2024 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 6,433 | $246K | 12/15/2023 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 5,028 | $364K | 6/15/2023 | View on chart |
| OMCL | ▲ Buy | Open Market | 4,000 | $295K | 6/8/2023 | View on chart |
| OMCL | ▲ Buy | Grant | 47,000 | $0 | 6/1/2023 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 8,652 | $419K | 12/15/2022 | View on chart |
| OMCL | ▲ Buy | Option Exercise | 2,500 | $43K | 12/1/2022 | View on chart |
| OMCL | ▼ Sell | Open Market | 900 | $46K | 12/1/2022 | View on chart |
| OMCL | ▼ Sell | Open Market | 1,600 | $81K | 12/1/2022 | View on chart |
| OMCL | ▼ Sell | Open Market | 13,000 | $1.4M | 8/16/2022 | View on chart |
| OMCL | ▼ Sell | Gift | 12,000 | $0 | 8/12/2022 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 8,728 | $987K | 6/15/2022 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 2,939 | $386K | 3/14/2022 | View on chart |
| OMCL | ▲ Buy | Grant | 41,430 | $0 | 3/14/2022 | View on chart |
| OMCL | ▲ Buy | Grant | 23,305 | $0 | 2/16/2022 | View on chart |
| OMCL | ▼ Sell | Tax Withholding | 8,888 | $0 | 12/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Omnicell Set to Release Q3 2026 Results; Guidance Update
Omnicell will publish its third‑quarter 2026 earnings on Oct. 29, 2026. Analysts noted the company beat revenue expectations but issued weaker EBITDA guidance, which may affect the bullish outlook. The stock is currently near its 12‑touch support level of $42.89 and trades below the average analyst target of $57.86.
Omnicell Set to Release Q3 2026 Results; Guidance Update. Omnicell will publish its third‑quarter 2026 earnings on Oct. 29, 2026. Analysts noted the company beat revenue expectations but issued weaker EBITDA guidance, which may affect the bullish outlook. The stock is currently near its 12‑touch support level of $42.89 and trades below the average analyst target of $57.86.